This cohort study examines the likelihood of and the factors associated with patients viewing their clinical notes within 4 weeks after a dermatology encounter.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy | 0 | 10.27 | 01-09-2026 |
| 2 | Postural Orthostatic Tachycardia Syndrome and Dermatomyositis | 0 | 9.48 | 01-09-2026 |
| 3 | Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma | 0 | 6.29 | 01-09-2026 |
| 4 | Golimumab in Treatment-Refractory Hidradenitis Suppurativa | 0 | 7.71 | 01-09-2026 |
| 5 | JAMA Dermatology | 0 | 5.68 | 01-09-2026 |
| 6 | Inflation-Adjusted Medicare Reimbursement for Common Dermatologic Procedures | 0 | 23.01 | 07-10-2026 |
| 7 | Melanoma Prevention Among Children of Melanoma Survivors | 0 | 8.06 | 07-10-2026 |
| 8 | Patient-Reported Exposure to Potentially Bogus Ophthalmic Treatments | 0 | 10.39 | 24-09-2026 |
| 9 | Treatment Adherence and Health Care Utilization After a First Episode of Psychosis | 0 | 7.77 | 24-09-2026 |
| 10 | JAMA+ Trials Editor’s Choice for Clinical Trial of 2025 in JAMA Dermatology | 0 | 6.57 | 01-09-2026 |